Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS)

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 2, 2008, Pages 369-374

  MacRae, Jennifer M ^a   Dojcinovic, Ivana ^b   Djurdjev, Ognjenka ^b   Jung, Beverly ^c   Shalansky, Steven ^b   Levin, Adeera ^b   Kiaii, Mercedeh ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; HEPARIN;

AGED; ARTICLE; CATHETERIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; THROMBOSIS;

AGED; ANTICOAGULANTS; CATHETERIZATION; CITRIC ACID; FEASIBILITY STUDIES; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; THROMBOSIS;

EID: 42549150104     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01760407     Document Type: Article

References (12)

1. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL: Haemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 21: 721-728, 2006
2. Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, Radkevich V, Murphy B: Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis. J Am Soc Nephrol 16: 201-209, 2005
3. Bayes B, Bonal J, Romero R: Sodium citrate for filling haemodialysis catheters. Nephrol Dial Transplant 14: 2532-2533, 1999
4. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P: Filling hemodialysis catheters in the interdialytic period: Heparin versus citrate versus polygeline: A prospective randomized study. Artificial Organs 22: 945-947, 1998
5. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM: Trisodium citrate 4%: an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22: 477-483, 2007
6. Grudzinski L, Quinan P, Kwok S, Pierratos A: Sodium citrate 4% locking solution for central venous dialysis catheters: An effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 22: 471-476, 2007
7. Weijmer M, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ; CITRATE Study Group: Randomized clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16: 2769-2777, 2005
8. Administration UFaD: FDA Issues Warning on Tricitasol Dialysis Catheter Anticoagulant. FDA Talk Paper TOO: 14, 2000
9. Meeus G, Kuypers D, Claes K, Evenepoel P, Maes B, Vanrenterghem Y: A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif 23: 101-105, 2004
10. Hendrickx L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y: A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 24: 206-211, 2001
11. Polaschegg HD, Sodemann K: Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant 18: 2688-2690, 2003
12. Macrae JM, Loh G, Djurdjev O, Shalansky S, Werb R, Levin A, Kiaii M: Short and long alteplase dwells in dysfunctional hemodialysis catheters. Hemodial Int 9: 189-195, 2005